Recent articles

The first of a series of three articles on the influence of drugs on the thyroid gland discusses the influence that drugs can have on the findings of laboratory assessments of thyroid values. It p ...

As a consequence of the publication of a number of randomised studies, Semaglutide has recently received much publicity as a possible treatment of obesity. In the Netherlands, semaglutide had been ...

This article discusses the results of the published randomised studies into the effect of corticosteroids in hospitalised patients with COVID-19. The RECOVERY study found a reduction of mortality ...

Several years after the introduction of the direct oral anticoagulants (DOACs), two specific antidotes were authorised. Idarucizumab reverses the action of the direct thrombin inhibitor dabigatran ...

Is it advisable to prescribe a low dose of colchicine (0.5 mg a day) as part of the secondary prevention of coronary heart disease? Several studies have assessed the efficacy of colchicine for thi ...

A number of monoclonal antibodies have been developed for use in patients infected with SARS-CoV-2. Clinical research has shown that these monoclonal antibodies inhibit viral replication in recent ...

Summary The oral blood glucose-lowering drug rosiglitazone has had a turbulent history. After its authorisation, it was found that the risk of myocardial infarction was larger with rosiglitazone ...

Published studies into the effects of tocilizumab in the treatment of patients with COVID-19 differ greatly in the way they have been designed and conducted. Comparisons are hampered by difference ...